Integrated Partner PainChek Logo



Pain often goes unrecognised and under-treated in people with communication difficulties such as dementia. PainChek Universal is a clinically validated smartphone-based medical device that enables best practice pain assessment for all people, everywhere.

PainChek Universal is a complete point-of-care solution that combines the existing PainChek® App with the Numerical Rating Scale (NRS). The PainChek integration in Person Centred Software enables best-practice pain management for all residents living with pain in any environment — from those who cannot verbalise pain to those who can, and those who fluctuate between the two – with no double handling of data.

The PainChek® App uses artificial intelligence and facial recognition to detect pain in those who cannot self-report. This gives a voice to those who cannot verbalise pain, whilst also driving objectivity and consistency in all assessments. For those who can self-report, PainChek Universal also includes access to the Numerical Rating Scale, a well-established standard used to document pain levels amongst these individuals. PainChek Universal also supports pain assessment using both tools at the point of care, for those residents whose ability to communicate fluctuates.

Using the Person Centred Software and PainChek Universal Integration, residential facilities can:

● Ensure greater consistency and continuity in pain management. Rest assured knowing all carers in your facility are using the same approach for pain assessment.

● Streamline the pain assessment process for time-poor carers, with access to the PainChek tool, the NRS, pain trends and charting in one solution.

● Simplify record-keeping and documentation to demonstrate compliance and support funding claims, with all your historical pain assessment records in one place.

PainChek® is currently being used in over 993 aged care facilities in Australia, the UK, Europe and Asia, and more than 300,000 pain assessments have been completed to date. Trials are also underway for a home care version of the App. Clinical trials are also planned for use with pre-verbal children and patients with delirium.



Visit website

Other Partners

View all Partners

Our Awards

ITAC 2022 Award Logo
Future of aging 2022 V2
Eldercare award 2022